CMBA
RBOT

C.M. Bidwell & Associates’s Vicarious Surgical RBOT Stock Holding History

C.M. Bidwell & Associates’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed -$5K – 593
2021
Q4 		$5K Hold
17
– – ﹤0.01% 438
2021
Q3 		$7K Hold
17
– – ﹤0.01% 415
2021
Q2 		$5K Buy
+17
New +$5.06K ﹤0.01% 467

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C.M. Bidwell & Associates's RBOT Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of Vicarious Surgical (RBOT) in Q1 2022, closing a stake of 17 shares — an estimated $5K sold.

C.M. Bidwell & Associates first reported a position in RBOT in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q3 2021. 61 funds tracked by Wall St. Rank hold RBOT as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining Vicarious Surgical position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 17 Vicarious Surgical shares in Q1 2022, an estimated $5K.
  • C.M. Bidwell & Associates first reported a position in Vicarious Surgical in Q2 2021 and held it in 3 quarters.
  • C.M. Bidwell & Associates's Vicarious Surgical position peaked at $7K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.